QA: Cyclo Therapeutics Inc. in us_chemicals/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000922247_2023_Cyclo_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000922247, Cyclo Therapeutics Inc.

  xvar xval
0 LiabilitiesCurrent 3,480,669
1 LiabilitiesNoncurrent 0
2 remainder_Liabilities 0
3 AssetsCurrent 4,158,555
4 PropertyPlantAndEquipmentNet 55,188
5 IntangibleAssets 0
6 AssetsNoncurrent 1,470
7 remainder_Assets 0
8 CostOfRevenue 0
9 SellingGeneralAndAdministrativeExpense 8,999,543
10 remainder_Expenses 7,998,103
11 remainder_Revenues 1,375,760
12 remainder_NetIncome 170,998
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 3,480,669
1 Assets 4,215,213
2 Expenses 16,997,646
3 Revenues 1,375,760
4 StockholdersEquity 734,544
5 NetIncome -15,450,888
6 ComprehensiveNetIncome -15,450,888
7 BaseVar 71,720,460
8 EconomicCapitalRatio -29.1

Edgar->Model Mapping

Feature Distribution

Change over Time